Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.75B | 2.79B | 2.75B | 2.50B | 2.00B | 1.37B |
Gross Profit | 417.15M | 420.37M | 446.95M | 472.32M | 412.59M | 289.88M |
EBITDA | 250.00K | 4.88M | -23.33M | 157.50M | 146.77M | 148.22M |
Net Income | -229.35M | -201.28M | -204.46M | -1.84M | 31.96M | 88.84M |
Balance Sheet | ||||||
Total Assets | 1.68B | 1.65B | 1.77B | 1.94B | 2.03B | 1.43B |
Cash, Cash Equivalents and Short-Term Investments | 115.96M | 112.58M | 2.22M | 14.45M | 133.14M | 183.28M |
Total Debt | 113.22M | 1.30B | 1.14B | 1.02B | 1.02B | 517.74M |
Total Liabilities | 1.76B | 1.69B | 1.61B | 1.59B | 1.65B | 1.01B |
Stockholders Equity | -87.63M | -38.47M | 156.19M | 354.56M | 373.27M | 411.61M |
Cash Flow | ||||||
Free Cash Flow | -121.14M | -34.04M | -125.26M | -43.45M | 165.52M | 336.29M |
Operating Cash Flow | -97.30M | -6.41M | -82.97M | -10.44M | 186.84M | 348.44M |
Investing Cash Flow | -23.84M | -27.63M | -42.29M | -111.81M | -685.63M | -635.01M |
Financing Cash Flow | 231.05M | 144.37M | 113.07M | 3.81M | 448.85M | 408.26M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $1.68B | 15.69 | 11.19% | 2.36% | 19.16% | 31.92% | |
64 Neutral | $1.95B | 11.27 | 10.38% | 1.65% | -8.86% | -36.22% | |
55 Neutral | €4.83B | 18.24 | -49.50% | 1.92% | 13.92% | -4.82% | |
53 Neutral | $907.19M | 267.24 | 42.49% | ― | 9.05% | ― | |
49 Neutral | $426.51M | ― | -4.00% | ― | -29.16% | -140.16% | |
49 Neutral | $46.65M | ― | -951.52% | ― | -0.70% | -2.38% | |
49 Neutral | $839.20M | 18.62 | -21.08% | ― | -18.13% | -215.78% |
On June 17, 2025, ModivCare Inc. held its annual meeting of stockholders where all proposed measures were approved, and the recommended director nominees were elected for a one-year term. The meeting also saw the approval of the executive officer compensation and the ratification of KPMG LLP as the independent registered public accounting firm for the 2025 fiscal year.
The most recent analyst rating on (MODV) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on ModivCare stock, see the MODV Stock Forecast page.
On May 5, 2025, Modivcare received a notification from Nasdaq regarding its market value of publicly held shares falling below the required threshold for continued listing. The company has until November 1, 2025, to regain compliance, with potential consequences including delisting or transferring to the Nasdaq Capital Market if compliance is not achieved. In its first quarter of 2025, Modivcare reported a service revenue decline to $650.7 million, a net loss of $50.4 million, and efforts to reduce costs and improve working capital efficiency. The company executed $105 million in new financing to support its transformation efforts and aims to generate over $20 million in annualized G&A savings.
On May 5, 2025, Modivcare announced the planned departures of its Chief Financial Officer, Barb Gutierrez, and Chief Information Officer, Jessica Kral, as part of its strategic business model evolution. The company will not replace these roles, relying instead on existing teams to support its modernization strategy, which includes cost reduction and technology-driven integration efforts. This leadership transition is part of a broader structural shift aimed at increasing organizational speed and accountability.
On April 25, 2025, Modivcare announced the appointment of Daniel Silvers to its board of directors, effective April 24, 2025, completing its plan to add three new independent directors. Mr. Silvers brings extensive experience in corporate finance and governance, which is expected to enhance Modivcare’s operational and financial strength. Concurrently, Craig Barbarosh, David Coulter, and Richard Kerley resigned from the board, with Coulter continuing as a board observer and Alexander Matina joining as a board observer.